Rachael Lester

Rachael Lester

Senior Vice President and Chief Business OfficeratCytomX Therapeutics· In the 2025 proxy

Pay in FY2025CytomX Therapeutics stock +313.6% the same year

Rachael Lester was paid $2.2M in FY2025 (Dec). CytomX Therapeutics stock rose 313.6% that year.

Pay$100 in the stock at the end of FY24 → $414
Pay is from the Summary Compensation Table of each CytomX Therapeutics proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Experience

  1. CytomX TherapeuticsPublic company · 1 yr
    • Senior Vice President and Chief Business Officer2025 – Present · 1 yrStock in role +121%

Roles come from the proxy statements of each company.

Activity

No new filings about this person in the feed.

For the press:Download CSVDownload PNGHow to use our data

Two people shown as one, or a wrong number?